{
  "trial_id": "NCT03820830",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Histologically confirmed invasive breast cancer",
      "label": "met",
      "evidence": "cytologically confirmed breast cancer"
    },
    {
      "criterion": "Completion of locoregional therapy",
      "label": "met",
      "evidence": "completion of gross excision of recurrence within 6 months prior to randomization"
    },
    {
      "criterion": "Negative or microscopically involved margins",
      "label": "met",
      "evidence": "negative margins"
    },
    {
      "criterion": "Female or male aged 18 years or older",
      "label": "met",
      "evidence": "45-year-old postmenopausal woman"
    },
    {
      "criterion": "ECOG performance status 0 or 1",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Recurrent tumor must be hormone receptor positive: ER+ and/or PgR+ \u22651% by IHC",
      "label": "met",
      "evidence": "ER/PR negative"
    },
    {
      "criterion": "Recurrent tumor must be HER2-negative (0, 1+, 2+ by IHC and/or ISH/FISH not amplified)",
      "label": "met",
      "evidence": "HER2-positive"
    },
    {
      "criterion": "The patient agrees to make tumor available for submission for central pathology review",
      "label": "met",
      "evidence": "the patient is a candidate for tumor resection and agrees to do so prior to chemotherapy"
    },
    {
      "criterion": "Patients must either be planned to initiate, or have already started, endocrine therapy for ipsilateral isolated locoregional recurrence",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Written Informed Consent prior to randomization",
      "label": "met",
      "evidence": "the patient agrees to do so prior to chemotherapy"
    },
    {
      "criterion": "Normal hematological, renal, and liver function",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "The patient is using multivitamins and iron supplements",
      "label": "met",
      "evidence": "the patient is using multivitamins and iron supplements"
    },
    {
      "criterion": "She does not smoke or consume alcohol",
      "label": "met",
      "evidence": "she does not smoke or consume alcohol"
    }
  ],
  "exclusion": [
    {
      "criterion": "Recurrence of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules) not surgically removable",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Evidence of distant metastasis as based on conventional staging examinations (physical, chest X-ray or CT, abdominal ultrasound or CT, bone scintigraphy or FDG-PET-CT)",
      "label": "not_met",
      "evidence": "CXR was remarkable for metastatic lesions"
    },
    {
      "criterion": "Bilateral synchronous or metachronous invasive breast cancer (in situ carcinoma of the contralateral breast is allowed)",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Inflammatory breast cancer",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Patients with a history of malignancy, other than invasive breast cancer, with the following exceptions:",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Previous treatment with palbociclib or any other CDK 4/6 inhibitors",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Previous or planned chemotherapy or planned radiotherapy for the ipsilateral isolated locoregional recurrence (radiotherapy is allowed, but must be completed more than 2 weeks prior to randomization)",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "45-year-old postmenopausal woman with cytologically confirmed breast cancer. A core biopsy revealed a 3 cm invasive ductal breast carcinoma in the left upper outer quadrant.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT03820830",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}